NCT02966522View on ClinicalTrials.gov

Thalidomide/Dexamethasone Treatment And PET Evaluation In Organ Involvemenet of Cardiac Amyloidosis

PHASE2UnknownINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions

Cardiac Amyloidosis

Interventions

DRUG

Thalidomide

DRUG

Dexamethasone

Trial Locations (1)

03080

RECRUITING

Seoul National University Hospital, Seoul

Sponsors

Collaborators (1)

CW pharmaceutical company

All Listed Sponsors

collaborator

CW pharmaceutical company

UNKNOWN

lead

Seoul National University Hospital

OTHER